Stocks · Health care · Pharmaceutical Preparations

Avalo Therapeutics, Inc.

AVTX Clue Score19
United States Fiscal year ends December CIK 0001534120 Results filed 5 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Jennifer Riley
11 Aug 2026
Chief Strategy Officer
Sell
2,655
$19.59
$52.01K

What was left out

Form 4 filings counted 66
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 35
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 777,657
History held since 20 Oct 2015